Using CRISPR to Fix Genetic Mutations in NEFL
Author Information
Author(s): Dua Poorvi H., Simon Bazilco M. J., Marley Chiara B.E., Feliciano Carissa M., Watry Hannah L., Steury Dylan, Abraham Abin, Gilbertson Erin N., Ramey Grace D., Capra John A., Conklin Bruce R., Judge Luke M.
Primary Institution: Cold Spring Harbor Laboratory
Hypothesis
Can haplotype editing with CRISPR/Cas9 effectively treat dominant-negative missense mutations in the NEFL gene?
Conclusion
The study shows that haplotype editing can potentially treat various NEFL mutations in motor neurons derived from stem cells.
Supporting Evidence
- The study validated haplotype editing for two different NEFL missense mutations.
- Gene inversion was found to be a frequent byproduct of the editing process.
- Alternative strategies were developed to improve editing outcomes.
Takeaway
Scientists are using a tool called CRISPR to fix genetic mistakes that cause diseases, which could help many people with similar problems.
Methodology
The researchers used CRISPR/Cas9 to edit specific genetic mutations in stem cell-derived motor neurons.
Limitations
The study primarily focuses on specific NEFL mutations and may not be applicable to all genetic disorders.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website